CoChat

EPI-001, A Compound Active against Castration-Resistant Prostate Cancer, Targets Transactivation Unit 5 of the Androgen Receptor

Open access
De Mol, Eva, Fenwick, R. Bryn, Phang, Christopher T. W., Buzón, Victor, Szulc, Elzbieta, de la Fuente, Alex, Escobedo, Albert, García, Jesús, Bertoncini, Carlos W., Estébanez-Perpiñá, Eva, McEwan, Iain J., Riera, Antoni, Salvatella, Xavier · 2016 · ACS Chemical Biology
Cited by 147

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Castration-resistant prostate cancer is the lethal condition suffered by prostate cancer patients that become refractory to androgen deprivation therapy. EPI-001 is a recently identified compound active against this condition that modulates the activity of the androgen receptor, a nuclear receptor that is essential for disease progression. The mechanism by which this compound exerts its inhibitory activity is however not yet fully understood. Here we show, by using high resolution solution nuclear magnetic resonance spectroscopy, that EPI-001 selectively interacts with a partially folded region of the transactivation domain of the androgen receptor, known as transactivation unit 5, that is key for the ability of prostate cells to proliferate in the absence of androgens, a distinctive feature of castration-resistant prostate cancer. Our results can contribute to the development of more potent and less toxic novel androgen receptor antagonists for treating this disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acschembio.6b00182

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 147

Metadata

Authors
De Mol, E., Fenwick, R. B., Phang, C. T. W., Buzón, V., Szulc, E., de la Fuente, A., Escobedo, A., García, J., Bertoncini, C. W., Estébanez-Perpiñá, E., McEwan, I. J., Riera, A., & Salvatella, X.
Venue
ACS Chemical Biology
Published
2016-07-14
Volume
11
Issue
9
Pages
2499-2505
ISSN
  • 1554-8929 (ISSN-L)
  • 1554-8937
OpenAlex
W2464082044
Cited by
147
References
8
FWCI
9.80
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: EPI-001, A Compound Active against Castration-Resistant Prostate Cancer, Targets Transactivation Unit 5 of the Androgen Receptor. https://app.cochat.ai/papers/10.1021/acschembio.6b00182
The paper
De Mol, E., Fenwick, R. B., Phang, C. T. W., Buzón, V., Szulc, E., de la Fuente, A., Escobedo, A., García, J., Bertoncini, C. W., Estébanez-Perpiñá, E., McEwan, I. J., Riera, A., & Salvatella, X. (2016). EPI-001, A Compound Active against Castration-Resistant Prostate Cancer, Targets Transactivation Unit 5 of the Androgen Receptor. ACS Chemical Biology. https://doi.org/10.1021/acschembio.6b00182

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.